Madrigal Pharmaceuticals, Inc.

Connor, Clark & Lunn Investment Management Ltd. MDGL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

58,295

Value ($000)

33,948

Weight

0.1%

2021 Q3 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	33,948	0.1%	58,295	12/31/2025
2025 Q3	11/13/2025	39,341	0.1%	85,773	9/30/2025
2025 Q2	8/7/2025	30,293	0.1%	100,095	6/30/2025
2025 Q1	5/12/2025	33,905	0.1%	102,360	3/31/2025
2024 Q4	2/10/2025	31,872	0.1%	103,288	12/31/2024
2024 Q3	11/8/2024	15,297	0.1%	72,083	9/30/2024
2024 Q2	8/9/2024	23,271	0.1%	83,062	6/30/2024
2024 Q1	5/9/2024	24,994	0.1%	93,597	3/31/2024
2023 Q4	2/9/2024	12,519	0.1%	54,107	12/31/2023
2023 Q3	11/13/2023	7,548	0.0%	51,686	9/30/2023
2023 Q2	8/10/2023	15,191	0.1%	65,761	6/30/2023
2023 Q1	5/10/2023	16,635	0.1%	68,664	3/31/2023
2022 Q4	2/10/2023	17,533	0.1%	60,407	12/31/2022
2022 Q3	11/10/2022	1,624	0.0%	24,989	9/30/2022
2022 Q2	8/5/2022	481	0.0%	6,725	6/30/2022
2022 Q1	5/12/2022	329	0.0%	3,349	3/31/2022
2021 Q4	2/10/2022	377	0.0%	4,445	12/31/2021
2021 Q3	11/12/2021	205	0.0%	2,574	9/30/2021